Parke Davis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PARKE DAVIS, and what generic and branded alternatives to PARKE DAVIS drugs are available?
PARKE DAVIS has one hundred approved drugs.
Drugs and US Patents for Parke Davis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | ERYC | erythromycin | CAPSULE, DELAYED REL PELLETS;ORAL | 062546-001 | Jul 25, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Parke Davis | HEPARIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 017346-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Parke Davis | CHOLEDYL | oxtriphylline | SOLUTION;ORAL | 009268-012 | Nov 27, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Parke Davis | PROCAN | procainamide hydrochloride | CAPSULE;ORAL | 085079-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Parke Davis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Parke Davis | CEREBYX | fosphenytoin sodium | INJECTABLE;INJECTION | 020450-001 | Aug 5, 1996 | 4,260,769 | ⤷ Sign Up |
Parke Davis | CHOLYBAR | cholestyramine | BAR, CHEWABLE;ORAL | 071621-001 | May 26, 1988 | 4,778,676 | ⤷ Sign Up |
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | 5,006,342 | ⤷ Sign Up |
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | 4,906,463 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PARKE DAVIS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Sublingual Tablets | 0.3 mg, 0.4 mg and 0.6 mg | ➤ Subscribe | 2005-10-19 |
➤ Subscribe | Sublingual Tablets | 0.6 mg | ➤ Subscribe | 2011-12-29 |
Similar Applicant Names
Here is a list of applicants with similar names.